MSK issues significantly impact employers and health plans due to increased healthcare costs and reduced employee productivity. For members, these conditions can impair quality of life, leading to chronic pain and mobility limitations. Effectively addressing MSK disorders is crucial to control costs, improve health outcomes, and enhance member well-being.

“Precision medicine is revolutionizing the healthcare industry, and our partnership with SimpleTherapy represents a significant step forward in this field,” said Tom Covington, CEO of Tag.bio. “By leveraging our powerful data mesh platform for analytics, we can provide SimpleTherapy and its customers with a more comprehensive understanding of patient data, enabling them to deliver more personalized and cost effective treatments.”

Arpit Khemka, Co-Founder & CEO of SimpleTherapy, expressed enthusiasm about the partnership, saying, “Our collaboration with Tag.bio represents a significant milestone for SimpleTherapy as we enhance our platform’s capabilities. This partnership reaffirms our commitment to providing genuine value, emphasizing transparency, long-term results, and unparalleled quality. We believe this alliance distinguishes us in the industry and ensures optimal outcomes for our clients and their members.”

Khemka added, “By integrating Tag.bio’s data mesh solution, we can empower healthcare providers to personalize physical therapy treatment plans, and enable employers and health plans to accurately evaluate and predict the impact on cost and outcomes. This ultimately leads to improved patient outcomes and reduced healthcare costs.”

About Tag.bio

Tag.bio, enables organizations to securely derive insights using data-as-products in a data mesh architecture. Customers use Tag.bio’s data science platform to discover, share, and unite diverse siloed data sets and execute workloads using no-code/low-code data mesh framework. The data science platform (available in AWS and Azure Marketplaces) combines data sets, smart APIs, statistical and machine learning algorithms into data products (application layer) for users to discover insights via apps. Learn more at: https://tag.bio

About SimpleTherapy®

SimpleTherapy, established in 2011, SimpleTherapy is a pioneer in digital musculoskeletal (MSK) pain recovery and mental health solutions, specifically designed for employers and health plans to provide their employees and members. By integrating evidence-based exercise therapy with cutting-edge artificial intelligence (AI) technology, SimpleTherapy delivers highly personalized care tailored to each participant’s condition, limitations, and therapeutic response. As a digital health company, SimpleTherapy focuses on offering evidence-based physical therapy solutions that enhance patient outcomes while lowering healthcare costs. The platform utilizes advanced analytics and machine learning algorithms to customize treatment plans for patients, ensuring optimal results. Learn more at: https://www.simpletherapy.com

Contacts

Media at SimpleTherapy: press@simpletherapy.com

Media at Tag.bio: info@tag.bio

Thanks to the support of Healthware Group as global co-host and main sponsor, and to the conference chairman, Roberto Ascione, Frontiers Health is recognised as one of the leading global health innovation events and has become the epicentre of the digital health ecosystem.

The conference agenda, in its second year as a hybrid physical-virtual experience, will feature partnership opportunities to run custom breakout sessions, corporate events, keynote speakers, discussion panels, plenary sessions, challenges, breakout sessions and more.

Themes

This year’s conference will explore topics inspired by healthcare, including:

Digital Therapeutics
Patent protections, regulatory developments, reimbursement strategies, data protection, open-sourcing healthcare

Digital Transformation
R&D transformation, health insurance trends, consumerization of healthcare, mjedical on-demand models, the connected patient

Telehealth
Patient centricity, remote monitoring, beyond episodic care, mental telehealth, big data & AI

Funding & Scaling
SPAC strategies, digital health IPOs, investments

Tickets

Take advantage of the Early Bird discount to get your ticket – digital or in-person – to attend the most important global event dedicated to digital health innovation!

Buy your pass to keep up to date with the global conference

European investment and regulation

The fast-tracking of global regulations on digital health has enabled wide roll-outs of solutions and in turn encouraged greater investment into the sector. European companies operating in the space have raised $11.8 billion, with France playing a leading role, both on the investors’ and funded companies’ side^[1].
We all know that reimbursement is a key challenge for many new digital health solutions. Since late last year Germany’s Digital Healthcare Act (Digitale–Versorgung–Gesetz) started to chart an important course for other European countries, even though some issues are yet to be resolved^[2].
Consequently, the pandemic period has seen France reimburse its first digital therapy in the form of Sivan’s Moovcare, which targets lung cancer^[3], while Belgium recently fully reimbursed moveUP, an mHealth app for the follow-up of patients after hip and knee replacement operations^[4].

Partnerships

On the companies’ side we have witnessed the establishment of a number of promising partnerships between digital health firms and pharma companies or other institutions.
One of these is a collaboration between Kaiku Health and Roche to co-develop novel digital patient monitoring and management modules in oncology.
The renewed partnership linking mobile care coordination and patient engagement platform Buddy Healthcare with Tampere University Hospital is another example, and will see Tampere implement Buddy’s platform to streamline its patient services and provide transparent and clear care pathways^[5].

Mental Health

The field’s next steps will be ensuring digital health is used today to deliver the best care to a global population in face of a mental health spike following the global emergency.
Digital therapy programmes that can offer courses of evidence-based treatments also have a role in the crisis, given their unique potential for scalability. In the first half of 2020, digital behavioural health start-ups scored $588 million, roughly the annual funding for this segment in any previous year^[6].

2 days of conference activities to dive into guiding themes inspired to healthcare trends and innovation topics: Breakthrough Innovations, Scientific and Medical Validation, Reimbursement and Business Models, Strategic Partnerships, Digital Therapies, Design for Health Transformation, Funding, M&A, path to value, Health Insurance Innovation.

2017 in numbers

500 delegates, 30 countries, 74 presentations, 130 startups and over 70 investors.

Book your seat and join the conversation!